LDLR and atherosclerosis: In contrast, those individuals carrying PCSK9 loss‐of‐function variants had increased numbers of their LDL receptors recirculated back to the cell surface, promoting the clearance of LDL‐C from circulation and potentially protecting against atherosclerosis [6].